Search
Mostrar filtros
Add filters:
Use filters to refine the search results.
Results 11-20 of 25 (Search time: 0.809 seconds).
| Issue Date | Title | Author(s) |
|---|---|---|
| 2013 | Pertuzumab (P) with trastuzumab (T) and chemotherapy (CTX) in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction (GEJ) cancer: An international phase III study (JACOB) | TABERNERO, Josep; HOFF, Paulo Marcelo; SHEN, Lin; OHTSU, Atsushi; YU, Ron; ENG-WONG, Jennifer; KANG, Yoon-Koo |
| 2013 | Cancer patients with ECOG-PS higher than 1: Who are those who benefit of palliative chemotherapy? | CAIRES-LIMA, Rafael; PROTASIO, Bruno Mendonca; CAIRES, Inacelli Queiroz de Souza; ROCHA, Lucila Soares Da Silva; OLIVEIRA, Julia Andrade De; GUERRA, Raquel Bezerra; MAK, Milena Perez; HOFF, Paulo M.; CASTRO, Gilberto |
| 2013 | Clinical characteristics at diagnosis of patients who survive more than 5 years after diagnosis of metastatic colorectal cancer (mCRC). | ABRAHAO, Manuel Cruz; SANTOS, Joao Paulo Velloso Medrado; PAVAN, Thayse; HOFF, Paulo M.; KATZ, Artur; SABBAGA, Jorge; AZEVEDO, Fernanda; FREITAS, Daniel; SARAGIOTTO, Daniel F.; COSTA, Frederico |
| 2012 | Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community setting | SANTANA, Iuri Amorim; OLIVEIRA, Julia Andrade De; AMARAL, Alan Alves; TESTA, Laura; LANDEIRO, Luciana Garcia; COSTA, Romulo Leopoldo de Paula; HAJIME, Marcelo; FERRARI, Marcela Simonis Martins; PETRY, Vanessa; COHN, Daniela J. B. Heinemann; HOFF, Paulo M.; MANO, Max S. |
| 2012 | Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME) | PETRY, Vanessa; LEAL, Alessandro; ARAI, Roberto J.; MARINHO, Simone; PAIVA, Marcelo; PIATO, Jose R.; ROSA, Marcio; HOFF, Paulo M.; MANO, Max S. |
| 2014 | Association between KRAS mutation and lung metastasis in advanced colorectal cancer | PEREIRA, Allan Andresson Lima; REGO, Juliana Florinda De Mendonga; MORRIS, Van Karlyle; OVERMAN, Michael J.; ENG, Cathy; GARRETT, Chris R.; FERRAROTTO, Renata; LEE, Michael Sangmin; JIANG, Zhiqin; HOFF, Paulo Marcelo; VAUTHEY, Jean-Nicolas; SANCHEZ, Eduardo Vilar; MARU, Dipen M.; KOPETZ, Scott |
| 2014 | A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment | MIRANDA, Vanessa Costa; FARIA, Luiza Dib; BRAGHIROLI, Maria Ignez Freitas Melro; JACOBS, Monica; SABBAGA, Jorge; HOFF, Paulo Marcelo; RIECHELMANN, Rachel Pimenta |
| 2014 | Colorectal high-grade neuroendocrine carcinoma: A single institution experience | CONTE, Bruno; GEORGE, Ben; DASARI, A.; OVERMAN, Michael J.; ESTRELLA, Jeannelyn; JIANG, Zhiqin; MACHADO, Karime; MELLO, Celso Lopes; FERRAROTTO, Renata; HOFF, Paulo M.; YAO, James C.; RASHID, Asif; KOPETZ, Scott |
| 2014 | Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal | RIBEIRO, Suilane Coelho; MONIZ, Camila Motta Venchiarutti; RIECHELMANN, Rachel; BARIANI, Giovanni Mendonca; BRAGHIROLI, Maria Ignez; NAHAS, Caio; COUDRY, Renata; ALEX, Alexandra Khichfy; CARNEIRO, Allyne Q.; NEBULONI, Daniela R.; GLASBERG, Joao; HOFF, Paulo |
| 2021 | KRAS MUTATIONS IN PATIENTS WITH NONSQUAMOUS NON-SMALL-CELL LUNG CANCER: PREVALENCE AND RELATIONSHIP WITH PD-L1 EXPRESSION, TUMOR MUTATION BURDEN AND SMOKING STATUS | GARASSINO, Marina Chiara; RODRIGUEZ-ABREU, Delvys; GADGEEL, Shirish M.; KOWALSKI, Dariusz M.; KASAHARA, Kazuo; FELIP, Enriqueta; WU, Yi-Long; CASTRO, Gilberto de; CHO, Byoung Chul; TURNA, Hande Z.; HORINOUCHI, Hidehito; RECK, Martin; HUI, Rina; GARON, Edward B.; BOYER, Michael; MOK, Tony S. K.; LOPES, Gilberto; KOBIE, Julie; LI, Yongjin; AYERS, Mark A.; CRISTESCU, Razvan; ZHAO, Bin; PIETANZA, M. Catherine; HERBST, Roy S. |